Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study (Journal of Gastroenterology, (2018), 53, 11, (1216-1224), 10.1007/s00535-018-1474-y);The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

Journal of Gastroenterology

Volumn 53, Issue 11, 2018, Pages 1216-1224

  Ishiba, Hiroshi ^a,b   Sumida, Yoshio ^c   Tanaka, Saiyu ^d   Yoneda, Masato ^e   Hyogo, Hideyuki ^f   Ono, Masafumi ^g   Fujii, Hideki ^h   Eguchi, Yuichiro ⁱ   Suzuki, Yasuaki ^j   Yoneda, Masashi ^k   Takahashi, Hirokazu ⁱ   Nakahara, Takashi ^k   Seko, Yuya ^b   Mori, Kojiro ^d   Kanemasa, Kazuyuki ^d   Shimada, Keiji ^d   Imai, Sunsuke ^d   Imajo, Kento ^e   Kawaguchi, Takumi ^l   Nakajima, Atsushi ^e   Chayama, Kazuaki ^k   Saibara, Toshiji ^g   Shima, Toshihide ^m   Fujimoto, Kazuma ⁱ   Okanoue, Takeshi ^m   Itoh, Yoshito ^b   more..

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d Nara City Hospital   (Japan)

^e YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JA Hiroshima General Hospital   (Japan)

^g KOCHI MEDICAL SCHOOL   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ SAGA UNIVERSITY   (Japan)

^j Nayoro City General Hospital   (Japan)

^k HIROSHIMA UNIVERSITY   (Japan)

^l KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m Saiseikai Imperial Gift Foundation Inc Saiseikai Suita Hospital   (Japan)

more..

Author keywords

Advanced fibrosis; Diagnostic accuracy; FIB4 index; Non alcoholic fatty liver disease; Non invasive fibrosis marker

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 7; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIB4 INDEX; GROUPS BY AGE; HUMAN; HUMAN TISSUE; JAPAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; PLATELET COUNT; PREDICTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; AGE; BIOPSY; BLOOD; CLINICAL TRIAL; COMPLICATION; LIVER; LIVER CIRRHOSIS; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 85046628830     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-018-1478-7     Document Type: Erratum

References (21)

1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.
2. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.
3. Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234–8.
4. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389–97.
5. Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547–54.
6. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28:705–12.
7. McPherson S, Stewart SF, Henderson E, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265–9.
8. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–54.
9. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57.
10. Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012;12:2.
11. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–25.
12. Shah AG, Lydecker A, Murray K, et al. Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104–12.
13. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
14. Japanese Society for the Study of Obesity. New criteria of obesity in Japanese. J Jpn Soc Study Obes. 2000;6:18–28.
15. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–97.
16. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
17. Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475–85.
18. Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145:782–9.
19. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.
20. Nagai Y, Metter EJ, Earley CJ, et al. Increased carotid artery intimal- medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation. 1998;98:1504–9.
21. McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112:740–51.